Cannabidiol is a substance extracted from the cannabis plant, Cannabis sativa, which acts on the central nervous system, being useful in the treatment of psychiatric or neurodegenerative diseases, such as multiple sclerosis, schizophrenia, Parkinson’s disease, epilepsy or anxiety, for example.
Currently, in Brazil, there is only one drug containing cannabidiol authorized for sale, the name Mevatyl, to which another substance, tetrahydrocannabinol, has been added, being indicated for the treatment of muscle spasms related to multiple sclerosis. Although only one drug containing this substance is already on the market, the trend is that in Brazil other cannabis-based medicines are approved, provided that its use is supervised by the doctor.
- In Brazil.
- There is only one cannabidiol-based drug authorized by Anvisa.
- Under the name Mevatyl.
- Which is indicated for the treatment of muscle spasms associated with multiple sclerosis.
However, there are other products containing cannabidiol, marketed in other countries, indicated for the treatment of epilepsy, Parkinson’s disease or Alzheimer’s disease, as analgesics in terminal cancer patients, for example, which can be imported, for specific cases and with corresponding authorization. .
There is still insufficient scientific evidence to show that cannabinoids are completely safe and effective in treating epilepsy, so there is only one indication of use in restricted cases, when other drugs indicated for this disease are not effective enough.
In addition, cannabidiol has also revealed other benefits and pharmacological properties, such as analgesic and immunosuppressive action, action in the treatment of stroke, diabetes, nausea and cancer and effects on anxiety, sleep and movement disorders, making it a substance of high therapeutic value. Potential. Learn more about the possible benefits of cannabidiol oil.
Watch the video below and discover the therapeutic benefits of cannabidiol:
The only cannabidiol drug authorized by Anvisa, is called Mevatyl, and is indicated for the treatment of muscle spasms associated with multiple sclerosis. This remedy is available in spray and can be purchased from pharmacies.
However, there are other products containing cannabidiol for other therapeutic purposes, which have been licensed for marketing in Brazil since March 2020, provided that it is obtained by prescription and a declaration of responsibility signed by the doctor and the patient.
The reported side effects are not only cannabidiol, but also tetrahydrocannabinol, as the drug Mevatyl contains both substances in its composition. Tetrahydrocannabinol, also known as THC, is a psychoactive substance and is therefore more likely to cause side effects.
Some of the most common side effects that may occur during treatment with Mevatyl are dizziness, changes in appetite, depression, disorientation, dissociation, euphoric mood, amnesia, balance and attention disorders, poor coordination of speech muscles, changes in taste, lack of energy, impaired memory, drowsiness, blurred vision, dizziness, constipation, diarrhea, burning, , pain and dry mouth, nausea and vomiting.